DEC 04, 2020 2:09 PM PST

OTC Drug Found Safe for Multiple Myeloma

WRITTEN BY: Nouran Amin

Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapsed or refractory multiple myeloma.

"These are exciting results for multiple myeloma patients," says Alfred L. Garfall, MD, an assistant professor of Medicine in the division of Hematology-Oncology in the Perelman School of Medicine at the University of Pennsylvania. "To have a single, subcutaneous-injectable drug that is effective in patients whose disease had become resistant to so many prior therapies, is well tolerated, and often yields long-lasting responses is a promising achievement."

Learn more about multiple myeloma:

Teclistamab is an antibody that triggers T cells to attack the multiple myeloma cells expressing B cell maturation antigen (BMCA).

"Teclistamab takes a similar approach to cellular therapies, which genetically engineer a patient's T cells to find and destroy cancer cells," Garfall said. "Except, this is jumpstarting the immune system with a single, off-the-shelf drug that takes 15 minutes to administer, in contrast to cellular therapies that take several weeks to manufacture for each patient."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
JAN 05, 2021
Drug Discovery & Development
Promising Epigenetic Treatment for Depression Works After One Dose
JAN 05, 2021
Promising Epigenetic Treatment for Depression Works After One Dose
Researchers affiliated with the University of Sao Paulo in Brazil have used epigenetic modulators to reduce stress-induc ...
JAN 27, 2021
Drug Discovery & Development
Researchers Discover How LSD Encourages Prosocial Behavior
JAN 27, 2021
Researchers Discover How LSD Encourages Prosocial Behavior
Researchers from McGill University have discovered one of the possible mechanisms by which lysergic acid diethylamide (L ...
FEB 26, 2021
Microbiology
Good Bacteria Fights Bad Bacteria in a Clinical Trial
FEB 26, 2021
Good Bacteria Fights Bad Bacteria in a Clinical Trial
Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, i ...
MAR 04, 2021
Infographics
All You Need to Know about COVID-19 Vaccines
MAR 04, 2021
All You Need to Know about COVID-19 Vaccines
After over a year lockdowns brought on by the pandemic, hopes for returning to something even similar to ' ...
MAR 04, 2021
Drug Discovery & Development
How Placebo Drugs for Pain Work in the Brain
MAR 04, 2021
How Placebo Drugs for Pain Work in the Brain
Researchers from Dartmouth College have found that pain relief drugs that work via the placebo effect reduce pain-relate ...
Loading Comments...